Loading
Latest filing published 17 Mar 2023 for Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)).
No signal scores available.
This profile gathers the share dealings of John London in Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). Altogether 2 filings, all relating to 14 March 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 17 March 2023 came the latest disclosure, a transaction in Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations